Related references
Note: Only part of the references are listed.A Novel YAP1 Inhibitor Targets CSC-Enriched Radiation-Resistant Cells and Exerts Strong Antitumor Activity in Esophageal Adenocarcinoma
Shumei Song et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Oncogenic Signaling Pathways in The Cancer Genome Atlas
Francisco Sanchez-Vega et al.
CELL (2018)
Inhibiting TRK Proteins in Clinical Cancer Therapy
Allison M. Lange et al.
CANCERS (2018)
A p53 Super-tumor Suppressor Reveals a Tumor Suppressive p53-Ptpn14-Yap Axis in Pancreatic Cancer
Stephano S. Mello et al.
CANCER CELL (2017)
Molecular Features of the YAP Inhibitor Verteporfin: Synthesis of Hexasubstituted Dipyrrins as Potential Inhibitors of YAP/TAZ, the Downstream Effectors of the Hippo Pathway
Floriane Gibault et al.
CHEMMEDCHEM (2017)
MARK4 inhibits Hippo signaling to promote proliferation and migration of breast cancer cells
Emad Heidary Arash et al.
EMBO REPORTS (2017)
Phosphorylation of Tyr188 in the WW domain of YAP1 plays an essential role in YAP1-induced cellular transformation
Ying-Wei Li et al.
CELL CYCLE (2016)
Nerve growth factor: role in growth, differentiation and controlling cancer cell development
Luigi Aloe et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2016)
Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer
Fa-Xing Yu et al.
CELL (2015)
PTPN14 Forms a Complex with Kibra and LATS1 Proteins and Negatively Regulates the YAP Oncogenic Function
Kayla E. Wilson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
A genetic screen identifies an LKB1-MARK signalling axis controlling the Hippo-YAP pathway
Morvarid Mohseni et al.
NATURE CELL BIOLOGY (2014)
The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment
Randy Johnson et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
The Hippo pathway and human cancer
Kieran F. Harvey et al.
NATURE REVIEWS CANCER (2013)
Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling
Fa-Xing Yu et al.
CELL (2012)
Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP
Yi Liu-Chittenden et al.
GENES & DEVELOPMENT (2012)
Nerve Growth Factor as a Signaling Molecule for Nerve Cells and also for the Neuroendocrine-Immune Systems
Marco Fiore et al.
REVIEWS IN THE NEUROSCIENCES (2011)
The Hippo Signaling Pathway in Development and Cancer
Duojia Pan
DEVELOPMENTAL CELL (2010)
YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway
Jianmin Zhang et al.
NATURE CELL BIOLOGY (2009)
Negative regulation of YAP by LATS1 underscores evolutionary conservation of the Drosophila Hippo pathway
Jianmin Zhang et al.
CANCER RESEARCH (2008)
Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control
Bin Zhao et al.
GENES & DEVELOPMENT (2007)
The Salvador-Warts-Hippo pathway - an emerging tumour-suppressor network
Kieran Harvey et al.
NATURE REVIEWS CANCER (2007)
Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon
Michael Overholtzer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Origin and evolution of the Trk family of neurotrophic receptors
E Benito-Gutiérrez et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2006)
Small-molecule inhibitors of protein-protein interactions: Progressing towards the dream
MR Arkin et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Trk receptor tyrosine kinases: A bridge between cancer and neural development
A Nakagawara
CANCER LETTERS (2001)
Nerve growth factor stimulates proliferation and survival of human breast cancer cells through two distinct signaling pathways
S Descamps et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
